|
|
| Line 20: |
Line 20: |
| ❑ Consider catheter ablation if antiarrhythmic therapy fails </div>}} | | ❑ Consider catheter ablation if antiarrhythmic therapy fails </div>}} |
| {{familytree/end}} | | {{familytree/end}} |
|
| |
| ==Anticoagulation Therapy==
| |
| Shown below are tables depicting the assessment of risk of stroke and the appropriate anticoagulation therapy among patients with Atrial flutter.<ref name="Fuster-2011">{{Cite journal | last1 = Fuster | first1 = V. | last2 = Rydén | first2 = LE. | last3 = Cannom | first3 = DS. | last4 = Crijns | first4 = HJ. | last5 = Curtis | first5 = AB. | last6 = Ellenbogen | first6 = KA. | last7 = Halperin | first7 = JL. | last8 = Kay | first8 = GN. | last9 = Le Huezey | first9 = JY. | title = 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. | journal = Circulation | volume = 123 | issue = 10 | pages = e269-367 | month = Mar | year = 2011 | doi = 10.1161/CIR.0b013e318214876d | PMID = 21382897 }}</ref>
| |
|
| |
| {| style="background: #FFFFFF;"
| |
| | valign=top |
| |
| {| style="float: left; cellpadding=0; cellspacing= 0; width: 600px;"
| |
| ! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center; colspan="2"| {{fontcolor|#FFF|Anticoagulation Therapy}}
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | '''''No risk factors''''' ||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Aspirin]] 81-325 mg daily'''''
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |'''''1 Moderate risk factor''''' || style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |▸ '''''[[Aspirin]] 81-325 mg daily''''' <br> ''OR'' <br> ▸ '''''[[Warfarin]] (INR 2.0 to 3.0, target 2.5)'''''
| |
| |-
| |
| |style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |'''''Any high risk factor or <br> more than 1 moderate risk factor''''' || style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |▸ '''''[[Warfarin]] (INR 2.0 to 3.0, target 2.5)'''''
| |
| |-
| |
| |}
| |
| |}
| |
| <br>
| |
|
| |
| {| style="cellpadding=0; cellspacing= 0; width: 600px;"
| |
| |-
| |
| | style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Low Risk Factors'''|| style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Moderate Risk Factors'''|| style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''High Risk Factors'''
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''Female gender'''''<BR>▸ '''''Age 65-74 years'''''<BR> ▸ '''''[[Coronary artery disease]]'''''<BR>▸ '''''[[Thyrotoxicosis]]'''''|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |▸ '''''Age ≥ 75 years'''''<BR>▸ '''''[[Hypertension]]'''''<BR> ▸ '''''[[Heart failure]]'''''<BR>▸ '''''LV [[ejection fraction]] ≤ 35%'''''<BR>▸ '''''[[Diabetes mellitus]]''''' || style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |▸ '''''Previous [[stroke]], [[TIA]] or [[embolism]]'''''<BR>▸ '''''[[Mitral stenosis]]'''''<BR> ▸ '''''[[Prosthetic heart valve]]'''''
| |
| |-
| |
| |}
| |